Validation of the Ankylosing Spondylitis Disease Activity Score with a Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study - ACR Meeting Abstracts
Por um escritor misterioso
Descrição
Background/Purpose: According to international recommendations, the Ankylosing Spondylitis Disease Activity Score (ASDAS) is the preferred score for assessing disease activity in axial spondyloarthritis (axSpA) [1]. However, routine determination of C-reactive protein (CRP) to calculate ASDAS values takes hours to days. This limits the use of ASDAS in clinical routine and clinical trials and hinders the […]
POS1104 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES
POS0683 AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT
The role of C-reactive protein as a predictor of treatment
ASDAS states in patients stratified by baseline MRI/CRP status
Disease Control Data, Ankylosing Spondylitis
Performance of the Ankylosing Spondylitis Disease Activity Score
PDF) POS0241 VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE
Validation of the Ankylosing Spondylitis Disease Activity Score
PDF) Performance of the Ankylosing Spondylitis Disease Activity
PDF) Performance of the Ankylosing Spondylitis Disease Activity
High disease activity according to the Ankylosing Spondylitis
Single Center: Most Up-to-Date Encyclopedia, News & Reviews
Gerd BURMESTER, Professor
J. Brandt-Juergens's research works
POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS
de
por adulto (o preço varia de acordo com o tamanho do grupo)
